[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69635612D1 - Detektion und amplifikation von nukleinsäuren durch chemische verbindung von oligonukleotiden - Google Patents

Detektion und amplifikation von nukleinsäuren durch chemische verbindung von oligonukleotiden

Info

Publication number
DE69635612D1
DE69635612D1 DE69635612T DE69635612T DE69635612D1 DE 69635612 D1 DE69635612 D1 DE 69635612D1 DE 69635612 T DE69635612 T DE 69635612T DE 69635612 T DE69635612 T DE 69635612T DE 69635612 D1 DE69635612 D1 DE 69635612D1
Authority
DE
Germany
Prior art keywords
oligonucleotides
amplification
detection
nucleic acids
chemical compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635612T
Other languages
English (en)
Other versions
DE69635612T2 (de
Inventor
David Segev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Publication of DE69635612D1 publication Critical patent/DE69635612D1/de
Application granted granted Critical
Publication of DE69635612T2 publication Critical patent/DE69635612T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69635612T 1995-05-01 1996-04-30 Detektion und amplifikation von nukleinsäuren durch chemische verbindung von oligonukleotiden Expired - Fee Related DE69635612T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US431527 1995-05-01
US08/431,527 US5843650A (en) 1995-05-01 1995-05-01 Nucleic acid detection and amplification by chemical linkage of oligonucleotides
PCT/US1996/006042 WO1996034984A1 (en) 1995-05-01 1996-04-30 Nucleic acid detection and amplification by chemical linkage of oligonucleotides

Publications (2)

Publication Number Publication Date
DE69635612D1 true DE69635612D1 (de) 2006-01-26
DE69635612T2 DE69635612T2 (de) 2006-10-19

Family

ID=23712327

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635612T Expired - Fee Related DE69635612T2 (de) 1995-05-01 1996-04-30 Detektion und amplifikation von nukleinsäuren durch chemische verbindung von oligonukleotiden

Country Status (7)

Country Link
US (1) US5843650A (de)
EP (1) EP0828856B1 (de)
JP (1) JP4216333B2 (de)
AU (1) AU5918396A (de)
CA (1) CA2217325C (de)
DE (1) DE69635612T2 (de)
WO (1) WO1996034984A1 (de)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767259A (en) 1994-12-27 1998-06-16 Naxcor Oligonucleotides containing base-free linking groups with photoactivatable side chains
EP2319855B1 (de) * 1997-01-08 2016-04-06 Sigma-Aldrich Co. LLC Biokonjugation von Makromolekülen
US6518017B1 (en) * 1997-10-02 2003-02-11 Oasis Biosciences Incorporated Combinatorial antisense library
US20030165888A1 (en) * 2001-07-18 2003-09-04 Brown Bob D. Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
US7427678B2 (en) 1998-01-08 2008-09-23 Sigma-Aldrich Co. Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
AU752220B2 (en) * 1998-01-27 2002-09-12 British Biocell International Limited Modified nucleic acid probes and uses thereof
EP1105539A2 (de) 1998-08-21 2001-06-13 Naxcor Testverfahren unter verwendung von vernetzbaren immobilisierten nukleinsäuren
US6303799B1 (en) 1998-11-10 2001-10-16 Naxcor Polynucleotide crosslinking agents
GB9825687D0 (en) * 1998-11-25 1999-01-20 Link Technologies Ltd Oligonucleotide conjugation
IL145586A0 (en) * 1999-04-08 2002-06-30 Oasis Biosciences Inc Antisense oligonucleotides comprising universal and/or degenerate bases
AU781802B2 (en) 1999-06-01 2005-06-16 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
US6200781B1 (en) 1999-06-25 2001-03-13 Integrated Genetic Devices, Ltd. Apparatus, system and method for automated execution and analysis of biological and chemical reactions
US6290831B1 (en) 1999-08-30 2001-09-18 Integrated Genetic Devices, Ltd. Electrophoretic system for real time detection of multiple electrophoresed biopolymers
WO2001067074A1 (en) * 2000-03-06 2001-09-13 The Johns Hopkins University Scatter controlled emission for optical taggants and chemical sensors
US6528318B1 (en) * 2000-03-06 2003-03-04 The Johns Hopkins University Scatter controlled emission for optical taggants and chemical sensors
US6573048B1 (en) * 2000-04-18 2003-06-03 Naxcor Degradable nucleic acid probes and nucleic acid detection methods
US20040067498A1 (en) * 2000-04-28 2004-04-08 Ahmed Chenna Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
US7727713B2 (en) * 2001-06-20 2010-06-01 Nuevolution A/S Templated molecules and methods for using such molecules
US7241566B2 (en) * 2001-06-22 2007-07-10 Marshfield Clinic Methods and oligonucleotides for the detection of Salmonella sp., E. coli O157:H7, and Listeria monocytogenes
DE10147074A1 (de) * 2001-09-25 2003-05-08 Beru Ag Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
CA2465588A1 (en) * 2001-11-09 2003-05-22 Aclara Biosciences, Inc. Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
DE20200926U1 (de) * 2002-01-23 2002-04-18 Hegenscheidt-MFD GmbH & Co. KG, 41812 Erkelenz Festwalzgerät einer Festwalzmaschine für Kurbelwellen
WO2003062452A2 (en) 2002-01-23 2003-07-31 Proligo, Llc Methods for the integrated synthesis and purification of oligonucleotides
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
DE60329277D1 (de) 2002-02-01 2009-10-29 Life Technologies Corp Oligonukleotidzusammensetzungen mit verbesserter effizienz
EP1487851A2 (de) * 2002-03-15 2004-12-22 Nuevolution A/S Ein baustein geeignet zur funktionellen gruppe übertragung zum nucleophil
CA2518626A1 (en) 2002-03-15 2003-09-25 Nuevolution A/S An improved method for synthesising templated molecules
EP1490384A2 (de) * 2002-03-15 2004-12-29 Nuevolution A/S Ein baublock zur c-c bindungsbildung
EP1487850A2 (de) * 2002-03-15 2004-12-22 Nuevolution A/S Ein baublock zur c-c bindungsbildung oder c-heteroatom bindungsbildung
US7211382B2 (en) * 2002-04-09 2007-05-01 Orchid Cellmark Inc. Primer extension using modified nucleotides
DK1636561T3 (da) 2002-07-15 2011-05-16 Univ Texas Kombinatorisk proteinbiblioteksscreening ved hjælp af periplasmatisk ekspression
WO2004013070A2 (en) 2002-08-01 2004-02-12 Nuevolution A/S Multi-step synthesis of templated molecules
EP2269618A1 (de) 2002-08-12 2011-01-05 Jennerex Biotherapeutics ULC Ein onkolytisches Vaccinia-Virus zur Verwendung in Kombination mit Chemotherapie zur Behandlung von Krebs
NZ538993A (en) 2002-10-30 2008-04-30 Nuevolution As Method for the synthesis of a bifunctional complex
EP1756277B1 (de) * 2002-12-19 2009-12-02 Nuevolution A/S Durch quasizufallsstrukturen und funktionen geführte synthesemethode
US7615629B2 (en) 2002-12-31 2009-11-10 Sigma-Aldrich Co. Methods and compositions for the tandem synthesis of two or more oligonucleotides on the same solid support
WO2004074429A2 (en) * 2003-02-21 2004-09-02 Nuevolution A/S Method for producing second-generation library
WO2004074501A2 (en) * 2003-02-21 2004-09-02 Nuevolution A/S A method for obtaining structural information about an encoded molecule
DE602004019764D1 (de) * 2003-03-20 2009-04-16 Nuevolution As Ligationsvermittelnde codierung von kleinen molekülen
KR100890885B1 (ko) 2003-03-31 2009-03-31 에프. 호프만-라 로슈 아게 일본 뇌염 바이러스 혈청군의 구성원을 포함하는, 특정플라비바이러스 검출용 조성물 및 방법
FR2855269B1 (fr) * 2003-05-21 2007-06-08 Commissariat Energie Atomique Dispositif et procedes d'accrochage/decrochage d'une cible ou d'un objet present dans un echantillon
JP4871722B2 (ja) 2003-07-25 2012-02-08 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー 固定試料からｒｎａを調製するための方法および組成物
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
US7087437B2 (en) * 2003-09-16 2006-08-08 Vici Gig Harbor Group, Inc. Direct vial surface sorbent micro extraction device and method
WO2005026387A1 (en) 2003-09-18 2005-03-24 Nuevolution A/S A method for obtaining structural information concerning an encoded molecule and method for selecting compounds
ATE447020T1 (de) * 2004-03-22 2009-11-15 Nuevolution As Ligationscodierung unter verwendung von oligonukleotidbausteinen
DE602005021525D1 (de) 2004-09-14 2010-07-08 Univ Colorado R behandlung mit bucindolol
US20060240442A1 (en) * 2005-04-20 2006-10-26 Vevea Dirk N Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
US20060246463A1 (en) * 2005-04-20 2006-11-02 Vevea Dirk N Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes
PL1877415T3 (pl) 2005-05-02 2011-02-28 Baseclick Gmbh Nowe strategie znakowania dla czułego wykrywania analitów
KR101335218B1 (ko) 2005-05-02 2013-12-12 바스프 에스이 분석물의 감응성 검출을 위한 신규한 표지화 전략
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
EP1933857A2 (de) 2005-09-07 2008-06-25 Jennerex Biotherapeutics ULC Systemische behandlung von metastasierten und/oder systemisch dissemierten tumoren mit gm-csf-exprimierenden pockenviren
US7910335B2 (en) 2005-10-27 2011-03-22 President And Fellows Of Harvard College Methods and compositions for labeling nucleic acids
WO2007062664A2 (en) 2005-12-01 2007-06-07 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
EP2368570A3 (de) 2006-01-18 2012-05-02 University Of Chicago Zusammensetzungen und Verfahren in Verbindung mit Stayphylokokken-Bakterienproteinen
US8114636B2 (en) 2006-02-10 2012-02-14 Life Technologies Corporation Labeling and detection of nucleic acids
US8716033B2 (en) 2006-02-10 2014-05-06 Life Technologies Corporation Oligosaccharide modification and labeling of proteins
EP2839837B1 (de) 2006-09-15 2019-05-08 Children's Hospital of Eastern Ontario Research Institute Inc. Onkolytisches farmington rhabdovirus
CA2667136A1 (en) 2006-10-31 2008-05-08 Baseclick Gmbh Click chemistry for the production of reporter molecules
ATE555128T1 (de) 2006-11-30 2012-05-15 Res Dev Foundation Verbesserte immunglobulin-bibliotheken
WO2008124847A2 (en) * 2007-04-10 2008-10-16 Nanostring Technologies, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
WO2008137475A2 (en) 2007-05-01 2008-11-13 Research Development Foundation Immunoglobulin fc libraries
MX2010003724A (es) * 2007-10-04 2010-09-14 Halcyon Molecular Secuenciacion de polimeros de acido nucleico con microscopia electronica.
CN104529711B (zh) 2007-11-21 2020-02-07 乔治亚大学研究基金公司 炔烃以及炔烃与1,3-偶极-官能化合物反应的方法
CN104263816B (zh) 2008-05-16 2018-10-19 生命技术公司 用于测量细胞增殖的双标记法
CA2739581A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial eap, emp, and/or adsa proteins
WO2011127032A1 (en) 2010-04-05 2011-10-13 University Of Chicago Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response
ES2563646T3 (es) 2009-04-03 2016-03-15 University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
EP2449104B1 (de) 2009-06-29 2014-06-04 Luminex Corporation Chimäre primer mit haarnadel-konformationen und verwendungsverfahren dafür
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
WO2011032088A1 (en) 2009-09-11 2011-03-17 Arca Biopharma, Inc. Polymorphisms in the pde3a gene
DK2477499T3 (en) 2009-09-14 2018-06-06 Sillajen Biotherapeutics Inc COMBINATION CANCER THERAPY WITH ONCOLYTIC VACCINIA VIRUS
AU2010329551B2 (en) 2009-12-10 2016-02-11 Turnstone Limited Partnership Oncolytic rhabdovirus
CA2822747A1 (en) 2009-12-23 2011-06-30 Arca Biopharma, Inc. Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
WO2011127933A1 (en) 2010-04-16 2011-10-20 Nuevolution A/S Bi-functional complexes and methods for making and using such complexes
KR20130093084A (ko) 2010-07-02 2013-08-21 더 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
AU2012204467B2 (en) 2011-01-04 2016-08-18 Sillajen, Inc. Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
JP6228014B2 (ja) 2011-02-07 2017-11-08 リサーチ ディベロップメント ファウンデーション 操作された免疫グロブリンＦｃポリペプチド
WO2012158238A2 (en) 2011-02-28 2012-11-22 University Of Iowa Research Foundation Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
US9057107B2 (en) 2011-03-08 2015-06-16 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
EP2694534B1 (de) 2011-04-08 2018-06-20 Evaxion Biotech ApS Proteine und nukleinsäuren zur verwendung für impstoffe gegen staphylococcus aureus
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US9364532B2 (en) 2011-06-08 2016-06-14 Children's Hospital Of Eastern Ontario Research Institute Inc. Compositions and methods for glioblastoma treatment
US10040853B2 (en) 2011-09-09 2018-08-07 Fred Hutchinson Cancer Research Center Methods and compositions involving NKG2D inhibitors and cancer
EP2766388A1 (de) 2011-10-12 2014-08-20 Møller, Niels Iversen Peptide aus campylobacter jejuni und ihre verwendung bei der impfung
ES2645418T3 (es) 2011-12-22 2017-12-05 Ibis Biosciences, Inc. Amplificación de una secuencia de un ácido ribonucleico
CA2861387A1 (en) 2012-02-02 2013-08-08 Invenra, Inc. High throughput screen for biologically active polypeptides
EP3805395A1 (de) 2012-04-26 2021-04-14 University Of Chicago Staphylokokken-coagulase-antigene und verfahren zu deren verwendung
EP2895622A4 (de) 2012-09-11 2016-05-18 Theranos Inc Informationsverwaltungssysteme und verfahren mit einer biologischen signatur
US10125373B2 (en) 2013-01-22 2018-11-13 Arizona Board Of Regents On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
RU2684211C2 (ru) 2013-02-21 2019-04-04 Тёрнстоун Лимитед Партнершип Композиция вакцины
CA2925004C (en) 2013-10-03 2019-04-30 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
EP3077820A1 (de) 2013-12-03 2016-10-12 Evaxion Biotech ApS Proteine und nukleinsäuren zur verwendung für impfstoffe gegen staphylococcus aureus
US20180169211A1 (en) 2014-11-13 2018-06-21 Evaxion Biotech Aps Peptides derived from acinetobacter baumannii and their use in vaccination
EP3224362B1 (de) 2014-11-26 2024-09-25 The Regents of The University of California Therapeutische zusammensetzungen mit transkriptionsfaktoren sowie verfahren zur herstellung und verwendung davon
EP4279080A3 (de) 2015-01-12 2024-02-21 Evaxion Biotech A/S Behandlung und prophylaxe von k.-pneumoniae-infektionen
CA2976236A1 (en) 2015-02-09 2016-08-18 Research Development Foundation Engineered immunoglobulin fc polypeptides displaying improved complement activation
EP3070178B1 (de) 2015-03-20 2020-02-12 Albert-Ludwigs-Universität Freiburg Verfahren zur diagnose von brustkrebs
US20180201656A1 (en) 2015-07-04 2018-07-19 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting Pseudomonas Aeruginosa
WO2017040380A2 (en) 2015-08-28 2017-03-09 Research Development Foundation Engineered antibody fc variants
EP3419654B1 (de) 2016-02-22 2022-04-27 Evaxion Biotech A/S In impfstoffen gegen staphylococcus aureus nützliche proteine und nukleinsäuren
EP3565576A1 (de) 2017-01-05 2019-11-13 Evaxion Biotech ApS Impfstoffe gegen pseudomonas aeruginosa
AU2018213315A1 (en) 2017-01-26 2019-07-25 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
EP3867645B1 (de) 2018-10-18 2024-06-05 Oklahoma Medical Research Foundation Biomarker für krankheitsaktivitätimmunindex von systemischem lupus erythematodes (sle) zur charakterisierung der krankheitsaktivität
WO2020083904A1 (en) 2018-10-22 2020-04-30 Evaxion Biotech Aps Vaccines targeting m. catharrhalis
EP3931206A1 (de) 2019-02-27 2022-01-05 Evaxion Biotech ApS Impfstoffe gegen h. influenzae
EP3772543B1 (de) 2019-08-09 2023-09-27 Albert-Ludwigs-Universität Freiburg Verfahren zur diagnose von brustkrebs
EP4087593A1 (de) 2020-01-06 2022-11-16 Evaxion Biotech A/S Impfstoffe, die gegen neisseria gonorrhoeae gerichtet sind
US20240010742A1 (en) 2022-06-10 2024-01-11 Research Development Foundation Engineered fcriib selective igg1 fc variants and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
CA2039517C (en) * 1990-04-03 2006-11-07 David Segev Dna probe signal amplification
HU218095B (hu) * 1990-05-01 2000-05-28 Amgen Inc. Eljárás átvitt szennyeződések csökkentésére, amplifikációs eljárásokban
US5424413A (en) * 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
US5846709A (en) * 1993-06-15 1998-12-08 Imclone Systems Incorporated Chemical process for amplifying and detecting nucleic acid sequences

Also Published As

Publication number Publication date
AU5918396A (en) 1996-11-21
CA2217325A1 (en) 1996-11-07
EP0828856B1 (de) 2005-12-21
JPH11504517A (ja) 1999-04-27
EP0828856A4 (de) 2001-11-21
EP0828856A1 (de) 1998-03-18
US5843650A (en) 1998-12-01
WO1996034984A1 (en) 1996-11-07
DE69635612T2 (de) 2006-10-19
JP4216333B2 (ja) 2009-01-28
CA2217325C (en) 2007-11-27

Similar Documents

Publication Publication Date Title
DE69635612D1 (de) Detektion und amplifikation von nukleinsäuren durch chemische verbindung von oligonukleotiden
DE69636843D1 (de) Nachweis von Nukleinsäure-Änderungen
DE69836885D1 (de) Nachweis von Nukleinsäuren durch Fluoreszenz quenching
DE69330834D1 (de) Quantitative detektierung von makromolekülen mit hilfe von fluoreszierenden oligonukleotiden
DE69426956D1 (de) Nachweis von Mycobakterien durch Nukleinsäure-Multiplexamplifizierung
DE69528670D1 (de) Nachweis von nukleinsäuren durch nuklease-katalysierte produktbildung
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
DE69424151D1 (de) Automatisierte synthese von oligonukleotiden
DE69935314D1 (de) Quantitatitative bestimmung von nucleinsäure-amplifizierungsprodukten
DE69431719D1 (de) Hybridisierung und sequenzierung von nukleinsäuren
DE69637518D1 (de) Homogene vervielfältigung und nachweis von nukleinsäuren
DE69637065D1 (de) Die bestimmung von nukleinsäuren und nukleinsäure-einheiten
DE69627122D1 (de) Nachweis von Polymorphismus
DE69620903D1 (de) Nachweiss von nukleinsäuren durch bildung von template abhängigen produkt
CA2159103A1 (en) Detection of human immunodeficiency virus type 1
DE69813986D1 (de) Herstellung von teilchen durch eine chemische reaktion
DE69325104D1 (de) Chemische weichmacher enthaltende papierprodukte
DE69633941D1 (de) Nachweis von unterschieden in nukleinsäuren
DE69821973D1 (de) Chemische änderung von elektrochemisch aktiviertem wasser
DE19532355B4 (de) Behandlung einer Öffnungsplatte mit selbstaufgebauten Monolagen bildenden chemischen Verbindungen
DE69331996D1 (de) Chemische Analyse durch Elektrophorese
DE69819998D1 (de) Verfahren zur chemischen Synthese von Oligonukleotiden
DE69317502D1 (de) Amplifikation und Nachweis von Nukleinsäurematerial
DE69817110D1 (de) Verfahren zur Herstellung von Kondensationsprodukten aus Hydroxy-substituierten Verbindungen und Glyoxylreagenzien
DE69522269D1 (de) Zurückgewinnung von Substanzen aus Abströmen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee